The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "Divided Infringement in the Life Sciences: Implications of Limelight v. Akamai " on August 7, 2014 beginning at 2:00 pm (ET). Ned Israelsen of Knobbe, Martens, Olson & Bear, LLP; Jonathan Singer of Fish & Richardson, PC; and Mark Stewart of Eli Lilly and Co. will examine the impact of the U.S. Supreme Court's recent opinion in Limelight v. Akamai on the life sciences. The webinar will review the following topics:
• Patent prosecution strategies for dealing with joint infringement issues,
• How litigation involving joint infringement in the life sciences is likely to play out, and
• How joint infringement uncertainties are likely to affect licensing other life science transactions.
The registration fee for the webinar is $130 (government and academic rates are available upon request). Those interested in registering for the webinar can do so here.